The Role of CD94/NKG2 in Innate and Adaptive Immunity

Overview

Journal Immunol Res

Specialty Allergy & Immunology

Date 2004 Jul 20

PMID 15258309

Citations 57

Authors

Anasuya Gunturi

Rance E Berg

James Forman

Affiliations

Soon will be listed here.

Abstract

CD94/NKG2 is a heterodimer expressed on natural killer (NK) and a small subset of T cells. This receptor varies in function as an inhibitor or activator depending on which isoform of NKG2 is expressed. The ligand for CD94/NKG2 is HLA-E in human and its homolog, Qa1 in mouse, which are both nonclassical class I molecules that bind leader peptides from other class I molecules. Although <5% of CD8 T cells express the receptor in a naïve mouse, its expression is upregulated upon specific recognition of antigen. Similar to NK cells, most CD8 T cells that express high levels of CD94 co-express NKG2A, the inhibitory isoform. The engagement of this receptor can lead to a blocking of cytotoxicity. However, these receptors have also been implicated in the cell survival of both NK and CD8 T cells. The level of CD94 expression is inversely correlated with the level of apoptosis in culture. Thus, CD94/NKG2 receptors may regulate effector functions and cell survival of NK cells and CD8 T cells, thereby playing a crucial role in the innate and adaptive immune response to a pathogen.

Citing Articles

Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study.

Itou T, Fujita K, Okuzono Y, Warude D, Miyakawa S, Mihara Y J Neuroinflammation. 2024; 21(1):331.

PMID: 39731185 PMC: 11674182. DOI: 10.1186/s12974-024-03327-w.

Association of IL1RN VNTR and NKG2A polymorphisms with hepatitis E infection, a case study from western India.

Tripathy A, Wagh P, Shahapure G, Walimbe A, Kadgi N, Nakate L Arch Virol. 2024; 169(12):250.

PMID: 39560779 DOI: 10.1007/s00705-024-06179-0.

Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD.

Shanley M, Daher M, Dou J, Li S, Basar R, Rafei H Cancer Cell. 2024; 42(8):1450-1466.e11.

PMID: 39137729 PMC: 11370652. DOI: 10.1016/j.ccell.2024.07.007.

An innovative single-cell approach for phenotyping and functional genotyping of CAR NK cells.

Sullivan M, Finocchiaro M, Yang Y, Thomas J, Ali A, Kaplan I J Immunother Cancer. 2024; 12(5).

PMID: 38821719 PMC: 11149162. DOI: 10.1136/jitc-2024-008912.

Monocytes in type 1 diabetes families exhibit high cytolytic activity and subset abundances that correlate with clinical progression.

Pant T, Lin C, Bedrat A, Jia S, Roethle M, Truchan N Sci Adv. 2024; 10(20):eadn2136.

PMID: 38758799 PMC: 11100571. DOI: 10.1126/sciadv.adn2136.

References

Derre L, Corvaisier M, Pandolfino M, Diez E, Jotereau F, Gervois N . Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy. J Immunol. 2002; 168(10):4864-70. DOI: 10.4049/jimmunol.168.10.4864. View

Aldrich C, DeCloux A, Woods A, Cotter R, Soloski M, Forman J . Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell. 1994; 79(4):649-58. DOI: 10.1016/0092-8674(94)90550-9. View

Soloski M, Metcalf E . The involvement of class Ib molecules in the host response to infection with Salmonella and its relevance to autoimmunity. Microbes Infect. 2002; 3(14-15):1249-59. DOI: 10.1016/s1286-4579(01)01485-x. View

Young N, Uhrberg M, Phillips J, Lanier L, Parham P . Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol. 2001; 166(6):3933-41. DOI: 10.4049/jimmunol.166.6.3933. View

Bellon T, Heredia A, Llano M, Minguela A, Rodriguez A, Lopez-Botet M . Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. J Immunol. 1999; 162(7):3996-4002. View

VANCE R, KRAFT J, Altman J, Jensen P, Raulet D . Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med. 1998; 188(10):1841-8. PMC: 2212405. DOI: 10.1084/jem.188.10.1841. View

Braud V, Allan D, OCallaghan C, Soderstrom K, DAndrea A, Ogg G . HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998; 391(6669):795-9. DOI: 10.1038/35869. View

Sivakumar P, Gunturi A, Salcedo M, Schatzle J, Lai W, Kurepa Z . Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. J Immunol. 1999; 162(12):6976-80. View

Speiser D, Pittet M, Valmori D, Dunbar R, Rimoldi D, Lienard D . In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med. 1999; 190(6):775-82. PMC: 2195637. DOI: 10.1084/jem.190.6.775. View

10.

Galiani M, Aguado E, Tarazona R, Romero P, Molina I, Santamaria M . Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals. Clin Exp Immunol. 1999; 115(3):472-6. PMC: 1905253. DOI: 10.1046/j.1365-2249.1999.00833.x. View

11.

Ida H, Robertson M, Voss S, Ritz J, Anderson P . CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. J Immunol. 1997; 159(5):2154-60. View

12.

Ugolini S, Arpin C, Anfossi N, Walzer T, CAMBIAGGI A, Forster R . Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat Immunol. 2001; 2(5):430-5. DOI: 10.1038/87740. View

13.

Raulet D, VANCE R, McMahon C . Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol. 2001; 19:291-330. DOI: 10.1146/annurev.immunol.19.1.291. View

14.

VANCE R, Jamieson A, Raulet D . Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J Exp Med. 1999; 190(12):1801-12. PMC: 2195720. DOI: 10.1084/jem.190.12.1801. View

15.

Moser J, Gibbs J, Jensen P, Lukacher A . CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol. 2002; 3(2):189-95. DOI: 10.1038/ni757. View

16.

Gunturi A, Berg R, Forman J . Preferential survival of CD8 T and NK cells expressing high levels of CD94. J Immunol. 2003; 170(4):1737-45. DOI: 10.4049/jimmunol.170.4.1737. View

17.

Bertone S, Schiavetti F, Bellomo R, Vitale C, Ponte M, Moretta L . Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol. 1999; 29(1):23-9. DOI: 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y. View

18.

McMahon C, Zajac A, Jamieson A, Corral L, Hammer G, Ahmed R . Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. J Immunol. 2002; 169(3):1444-52. DOI: 10.4049/jimmunol.169.3.1444. View

19.

Tarazona R, DelaRosa O, G Casado J, Torre-Cisneros J, Villanueva J, Galiani M . NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56. AIDS. 2002; 16(2):197-200. DOI: 10.1097/00002030-200201250-00008. View

20.

Le Drean E, Vely F, Olcese L, CAMBIAGGI A, Guia S, Krystal G . Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol. 1998; 28(1):264-76. DOI: 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O. View